ATC code A03

ATC code A03 Drugs for functional gastrointestinal disorders is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3] Subgroup A03 is part of the anatomical group A Alimentary tract and metabolism.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA03.^[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

A03A Drugs for functional gastrointestinal disorders

A03AA Synthetic anticholinergics, esters with tertiary amino group

A03AA01 Oxyphencyclimine

A03AA03 Camylofin

A03AA04 Mebeverine

A03AA05 Trimebutine

A03AA06 Rociverine

A03AA07 Dicycloverine

A03AA08 Dihexyverine

A03AA09 Difemerine

A03AA30 Piperidolate

A03AB Synthetic anticholinergics, quaternary ammonium compounds

A03AB01 Benzilone

A03AB02 Glycopyrronium bromide

A03AB03 Oxyphenonium

A03AB04 Penthienate

A03AB05 Propantheline

A03AB06 Otilonium bromide

A03AB07 Methantheline

A03AB08 Tridihexethyl

A03AB09 Isopropamide

A03AB10 Hexocyclium

A03AB11 Poldine

A03AB12 Mepenzolate

A03AB13 Bevonium

A03AB14 Pipenzolate

A03AB15 Diphemanil

A03AB16 (2-benzhydryloxyethyl)diethyl-methylammonium iodide

A03AB17 Tiemonium iodide

A03AB18 Prifinium bromide

A03AB19 Timepidium bromide

A03AB21 Fenpiverinium

A03AB53 Oxyphenonium, combinations

QA03AB90 Benzetimide

QA03AB92 Carbachol

QA03AB93 Neostigmin

A03AX15 Menthae piperitae aetheroleum

A03AX30 Trimethyldiphenylpropylamine

A03AX58 Alverine, combinations

QA03AX63 Silicones, combinations

QA03AX90 Physiostigmin

QA03AX91 Macrogol ricinoleat (NFN)

A03B Belladonna and derivatives, plain

A03BA Belladonna alkaloids, tertiary amines

A03BA01 Atropine

A03BA03 Hyoscyamine

A03BA04 Belladonna total alkaloids

A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds

A03BB01 Butylscopolamine

A03BB02 Methylatropine

A03BB03 Methylscopolamine

A03BB04 Fentonium

A03BB05 Cimetropium bromide

A03BB06 Homatropine methylbromide

A03C Antispasmodics in combination with psycholeptics

A03CA Synthetic anticholinergic agents in combination with psycholeptics

A03CA01 Isopropamide and psycholeptics

A03CA02 Clidinium and psycholeptics

A03CA03 Oxyphencyclimine and psycholeptics

A03CA04 Otilonium bromide and psycholeptics

A03CA05 Glycopyrronium and psycholeptics

A03CA06 Bevonium and psycholeptics

A03CA07 Ambutonium and psycholeptics

A03CA08 Diphemanil and psycholeptics

A03CA09 Pipenzolate and psycholeptics

A03CA30 Emepronium and psycholeptics

A03CA34 Propantheline and psycholeptics

A03CB Belladonna and derivatives in combination with psycholeptics

A03CB01 Methylscopolamine and psycholeptics

A03CB02 Belladonna total alkaloids and psycholeptics

A03CB03 Atropine and psycholeptics

A03CB04 Homatropine methylbromide and psycholeptics

A03CB31 Hyoscyamine and psycholeptics

A03CC Other antispasmodics in combination with psycholeptics

A03D Antispasmodics in combination with analgesics

A03DA Synthetic anticholinergic agents in combination with analgesics

A03DA01 Tropenzilone and analgesics

A03DA02 Pitofenone and analgesics

A03DA03 Bevonium and analgesics

A03DA04 Ciclonium and analgesics

A03DA05 Camylofin and analgesics

A03DA06 Trospium and analgesics

A03DA07 Tiemonium iodide and analgesics

A03DB Belladonna and derivatives in combination with analgesics

A03DB04 Butylscopolamine and analgesics

A03DC Other antispasmodics in combination with analgesics

A03E Antispasmodics and anticholinergics in combination with other drugs

A03EA Antispasmodics, psycholeptics and analgesics in combination

A03ED Antispasmodics in combination with other drugs

A03F Propulsives

A03FA Propulsives

A03FA01 Metoclopramide

A03FA02 Cisapride

A03FA03 Domperidone

A03FA04 Bromopride

A03FA05 Alizapride

A03FA06 Clebopride

A03FA07 Itopride

A03FA08 Cinitapride

A03FA09 Mosapride

A03FA10 Acotiamide

QA03FA90 Physiostigmine

References

^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^ "ATC/DDD Index 2022: code A03". WHO Collaborating Centre for Drug Statistics Methodology.
^ "ATCvet Index 2022: code QA03". WHO Collaborating Centre for Drug Statistics Methodology.

[1] "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.

[2] World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.

[3] "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.

[4] "ATC/DDD Index 2022: code A03". WHO Collaborating Centre for Drug Statistics Methodology.

[5] "ATCvet Index 2022: code QA03". WHO Collaborating Centre for Drug Statistics Methodology.

[1]

[2]

[3]

[4]

[5]

ATC code A: Alimentary tract and metabolism
A01 Stomatological preparations A02 Drugs for acid related disorders A03 Drugs for functional gastrointestinal disorders A04 Antiemetics and antinauseants A05 Bile and liver therapy A06 Drugs for constipation A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents A08 Antiobesity preparations, excluding diet products A09 Digestives, including enzymes A10 Drugs used in diabetes A11 Vitamins A12 Mineral supplements A13 Tonics A14 Anabolic agents for systemic use A15 Appetite stimulants A16 Other alimentary tract and metabolism products
Other ATC codes
A B C D G H QI J L M N P R S V